Published in Medical Letter on the CDC and FDA, June 5th, 2005
OncoVEX GM-CSF is an oncolytic virus that selectively kills tumor cells. It also induces tumor cells to secrete GM-CSF, a powerful immune stimulator, potentially enhancing the destruction of both injected and metastatic tumor deposits.
"Submitting an IND for OncoVEX GM-CSF is a significant milestone for BioVex" said Gareth Beynon, CEO of BioVex. "We believe the combination of oncolytic activity with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.